Early Trial Tests Ontorpacept Plus Doxorubicin for Advanced Leiomyosarcoma
A new Phase 1/2 clinical study is testing whether an immune-targeting drug can make chemotherapy more effective against high-grade leiomyosarcoma, ...
A new Phase 1/2 clinical study is testing whether an immune-targeting drug can make chemotherapy more effective against high-grade leiomyosarcoma, ...
In the ever-evolving landscape of cancer therapy, recent advances have spotlighted pyroptosis, a form of programmed cell death, as a ...
Liver cancer remains one of the most formidable challenges in oncology, especially for millions affected by fatty liver disease globally. ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine